163 related articles for article (PubMed ID: 32434367)
1. Olanzapine: is it enough for CINV prevention?
Tienchaiananda P; Nipondhkit W; Prasongsook N
Ann Palliat Med; 2020 Jul; 9(4):2427-2429. PubMed ID: 32434367
[No Abstract] [Full Text] [Related]
2. A meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomiting.
Wang XF; Feng Y; Chen Y; Gao BL; Han BH
Sci Rep; 2014 Apr; 4():4813. PubMed ID: 24770591
[TBL] [Abstract][Full Text] [Related]
3. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
Natale JJ
Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine 5 mg vs 10 mg for the prophylaxis of chemotherapy-induced nausea and vomiting: a network meta-analysis.
Chow R; Navari RM; Terry B; DeAngelis C; Prsic EH
Support Care Cancer; 2022 Feb; 30(2):1015-1018. PubMed ID: 34613472
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review.
Chow R; Chiu L; Navari R; Passik S; Chiu N; Popovic M; Lam H; Pasetka M; Chow E; DeAngelis C
Support Care Cancer; 2016 Feb; 24(2):1001-1008. PubMed ID: 26530228
[TBL] [Abstract][Full Text] [Related]
6. Cancer and chemotherapy-induced nausea and vomiting: a focus on olanzapine.
Bosnjak SM; Dimitrijevic J; Djordjevic F
Curr Opin Support Palliat Care; 2016 Jun; 10(2):180-8. PubMed ID: 27028050
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine for chemotherapy-induced nausea and vomiting control - Authors' reply.
Bajpai J; Pawar A; Kapu V; Prabhash K
Lancet Oncol; 2024 May; 25(5):e177. PubMed ID: 38697160
[No Abstract] [Full Text] [Related]
8. Olanzapine for nausea and vomiting.
Licup N
Am J Hosp Palliat Care; 2010 Sep; 27(6):432-4. PubMed ID: 20508243
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine in the treatment of refractory nausea and vomiting: a case report and review of the literature.
Langley-DeGroot M; Ma JD; Hirst J; Roeland EJ
J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):148-52. PubMed ID: 26095486
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy.
Slimano F; Netzer F; Borget I; Lemare F; Besse B
Int J Clin Pharm; 2018 Oct; 40(5):1265-1271. PubMed ID: 29744791
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine for chemotherapy-induced nausea and vomiting control.
Radhakrishnan V; Seshadri RA; Nair S
Lancet Oncol; 2024 May; 25(5):e174. PubMed ID: 38697157
[No Abstract] [Full Text] [Related]
12. Olanzapine for chemotherapy-induced nausea and vomiting control.
Tsuruta S; Matsuguma K; Kawasaki N; Ishikawa A; Ishiki H
Lancet Oncol; 2024 May; 25(5):e176. PubMed ID: 38697159
[No Abstract] [Full Text] [Related]
13. Olanzapine for chemotherapy-induced nausea and vomiting control.
Sharma V; Dadheech A; Yadav A; Pehalajani JK; Somani N
Lancet Oncol; 2024 May; 25(5):e175. PubMed ID: 38697158
[No Abstract] [Full Text] [Related]
14. The emerging role of olanzapine in paediatric CINV control: A review.
Barušić AK
Medicine (Baltimore); 2022 Dec; 101(50):e32116. PubMed ID: 36550859
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine for preventing nausea and vomiting induced by moderately and highly emetogenic chemotherapy.
Wang SY; Yang ZJ; Zhang L
Asian Pac J Cancer Prev; 2014; 15(22):9587-92. PubMed ID: 25520071
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis.
Yoodee J; Permsuwan U; Nimworapan M
Crit Rev Oncol Hematol; 2017 Apr; 112():113-125. PubMed ID: 28325253
[TBL] [Abstract][Full Text] [Related]
17. QoL evaluation of olanzapine for chemotherapy-induced nausea and vomiting comparing with 5-HT3 receptor antagonist.
Liu J; Tan L; Zhang H; Li H; Liu X; Yan Z; Chen J; Yang H; Zhang D
Eur J Cancer Care (Engl); 2015 May; 24(3):436-43. PubMed ID: 25404537
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine is an effective antiemetic agent.
Navari RM; Loprinzi CL
Ann Palliat Med; 2020 May; 9(3):628-630. PubMed ID: 32498523
[No Abstract] [Full Text] [Related]
19. Olanzapine Reduces Chemotherapy-induced Nausea and Vomiting Compared With Aprepitant in Myeloma Patients Receiving High-dose Melphalan Before Stem Cell Transplantation: A Retrospective Study.
Trifilio S; Welles C; Seeger K; Mehta S; Fishman M; McGowan K; Strejcek K; Eiten E; Pirotte C; Lucier E; DeFrates S; Mehta J
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):584-589. PubMed ID: 28694084
[TBL] [Abstract][Full Text] [Related]
20. [Medical treatment of chemotherapy-induced nausea and vomiting].
Herrstedt J
Ugeskr Laeger; 2007 Feb; 169(9):799-805. PubMed ID: 17355844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
